Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone therapy can improve sexual satisfaction and mood in surgically menopausal women when used with estrogen, but its long-term safety and effects on naturally menopausal and premenopausal women are unclear.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Minoxidil and spironolactone slow hair loss in women.

The document suggests that Alopecia X in dogs is mainly a cosmetic issue and might be better left untreated.

Castration is preferred for non-breeding male dogs with BPH, but other treatments are available with specific pros and cons.

Alopecia patients have less GPER-1, which might affect hair loss.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Estrogen therapy can reduce skin aging but has cancer risks.

New targets for making and using brain-synthesized steroids could lead to better treatments for brain disorders and alcoholism.

Estrogens help reduce skin aging, and SERMs might offer similar benefits without the risks of hormone therapy.

New treatments for male hypogonadism are effective and should be personalized.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Prostaglandin D₂ might be targeted for new male pattern baldness treatments.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

Pregnant women often experience skin and hair changes, with over half getting stretch marks and pigment changes, and should be cautious with cosmetic procedures due to potential risks.

Testosterone replacement may improve sexual desire and bone health in women with low androgen levels, but more research is needed on its long-term safety.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Long-term finasteride use doesn't change bone density or metabolism.

Women with early hair loss have higher blood pressure and aldosterone; screening and treatment may help.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

Hair growth slows and shedding increases after childbirth, but most women don't experience excessive hair loss.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Hormonal treatments are effective as a second-line option for moderate-to-severe acne in females, but should be used with caution due to health risks.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Finasteride and dutasteride effectively treat hair loss in men and women, but may cause side effects like low libido and depression.